Dr. Reddy’s – Growing The Core, Building The Future: ICICI Securities

Dr. Reddy’s Laboratories Ltd. hosted an investor day call on June 21, 2022. We have summarised the key highlights below:

Dr. Reddy’s has devised a two-pronged strategy to drive long-term growth, classified as Horizon 1 and Horizon 2.

Horizon 1 – Growing the core, short-medium term drivers of growth

  • US: Grow injectables business and strengthen the over-the-counter segment.

  • Europe: Aims to build scale in EU5 (Germany, UK, Spain, France and Italy), targets selective expansion to other markets and more first to market launches.

  • India: Build big brands, win in chosen therapies/disease areas through differentiated portfolio and inorganic play, and improve productivity.

  • Emerging market: Grow mega brands in Rx and OTC.

Horizon 2 – Building the future, short-long term drivers of growth.

  • US: Focus on biosimilar, drug device combinations and immuno-oncology.

  • Europe: Aims to grow branded businesses, pioneer into new spaces (eg: pharmaceutical cannabis and scale-up of biosimilars).

  • India: Target segments such as nutraceuticals, OTC, biologics and CAR-T, new chemical entity/new biologic entity and disease management.

  • Emerging market: Focus on differentiated formulations, nutrition portfolio, biologics, NCE.

Most Related Links :
honestcolumnist Governmental News Finance News

Source link

Back to top button